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INTRODUCTION 
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Periodontal disease is the leading cause of tooth loss in adults.  Bacterial biofilm 
on tooth surfaces is the primary initiator of periodontal disease.  Various factors 
contribute to the severity of periodontal disease including the different virulence factors 
of the bacteria within the biofilm.  In the progression of periodontal disease, the 
microflora evolves from a predominantly Gram positive microbial population to a mainly 
Gram negative population.  Specific gram negative bacteria with pronounced virulence 
factors have been implicated in the etiology and pathogenesis of periodontal disease, 
namely Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola which 
form the red complex of bacteria.  The orange complex bacteria become more dominant 
in the maturation process of dental plaque and act to bridge the early colonizers of plaque 
with the later more dominant red complex bacterial and consists of such bacteria as 
Campylobacter showae, Campylobacter rectus, Fusobacterium nucleatum and Prevotella 
intermedia.  Perhaps the most investigated contributing factor is the relationship between 
smoking and periodontal disease.  When examining the association between cigarette 
smoking and interproximal bone loss, greater bone loss is associated with higher cigarette 
consumption, longer duration (i.e., pack year history) and higher lifetime exposure.  The 
presence of various virulence factors such as the production of a capsular material, as 
well as the proteolytic activity of the various periopathodontic bacteria has been 
associated with the pathogenesis of periodontitis.  Even though many different enzymes 
are produced in large quantities by these periodontal bacteria, trypsin-like enzymes, 
chymotrypsin-like enzymes and elastase-like enzymes, as well as dipeptidyl peptidase-
like enzymes, have been thought to increase the destructive potential of the bacterium and 
mediate destruction of the periodontal apparatus. 
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PURPOSE OF THE STUDY 
The objective of this study was to determine the effects of nicotine on the secreted 
enzymatic activity of P. intermedia, F. nucleatum and Porphyromonas assacharolyticus.   
 
HYPOTHESES 
Hypothesis 
We hypothesize that the secreted enzymatic activity of P. intermedia, F. nucleatum 
and P. assacharolyticus will be increased in the presence of nicotine versus the absence 
of nicotine. 
Null Hypothesis  
The secreted enzymatic activity of P. intermedia, F. nucleatum and P. 
assacharolyticus will be unchanged in the presence of nicotine.  
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REVIEW OF LITERATURE 
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Periodontal diseases are the leading cause of tooth loss in adults.  These diseases 
affect the tooth-supporting tissues resulting in progressive destruction of the attachment 
apparatus and is characterized by gingival bleeding, alveolar bone destruction, 
progressive tooth mobility and subsequent tooth loss.  Albandar et al. analyzed National 
Health and Nutrition Examination Survey III - (NHANES-III) data from 1988 to 1994 
and estimated that approximately 35% of the dentate U.S. adults aged 30 to 90 have 
periodontitis, 21.8% having a mild form and 12.6% having a moderate or severe form
1
.  
Bacterial biofilm on tooth surfaces is the primary initiator of periodontal disease.  This is 
further propagated by the host responses to the biofilm.  Various factors contribute to the 
severity of periodontal disease including the presence of different virulence factors of the 
bacteria within the biofilm.   
Commensal microflora of the oral cavity are responsible for most forms of 
periodontitis
2, 3
.  In the progression of periodontal disease, the microflora progresses from 
a Gram positive microbial population to a predominantly Gram negative population.  
Specific gram negative bacteria with pronounced virulence factors have been implicated 
in periodontal disease, namely Porphyromonas gingivalis and Tannerella forsythia 
3
.  
According to Socransky et al., the red complex of periodontopathic bacteria has been 
found to be associated with chronic periodontitis and includes P. gingivalis, T. forsythia 
and Treponema denticola 
4
.  The orange complex bacteria, also described by Socransky 
et al., are thought to become more dominant in the maturation process of dental plaque 
and act to bridge the early colonizers of plaque with the later more dominant red complex 
bacteria.  The orange complex consists of such bacteria as Campylobacter showae, 
Campylobacter rectus, Fusobacterium nucleatum and Prevotella intermedia (Figure 1). 
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Associated with the late colonizers of the red complex, P. gingivalis is an 
opportunistic, anaerobic, non-motile, Gram negative bacillus.  Subgingival colonization 
by P. gingivalis is facilitated by the ability of the bacterium to adhere to the available 
substrates such as absorbed salivary molecules, matrix proteins, epithelial cells and other 
bacteria which have established a biofilm on the tooth and epithelial surfaces
5
.  P. 
gingivalis can be a difficult bacterium to culture and subsequently grow in laboratory 
conditions.  Thus a suitable alternative, even though it is not a periodontal pathogen per 
se, is Porphyromonas assacharolyticus.  Shah and Collins in 1988 proposed a 
reclassification of the genus Bacteroides to the genus Porphyromonas and stated that 
Bacteroides assacharolyticus, Bacteroides gingivalis, and Bacteroides endodontalis are 
well-defined species and on the basis of biochemical and chemical properties form a 
relatively homogeneous group quite unrelated to the type species of the genus 
Bacteroides and should be reclassified as Porphyromonas assacharolyticus, 
Porphyromonas gingivalis and Porphyromonas endodontalis 
6
.  They noted that the 
proteolytic activity of this genus in general is variable but is exhibited in all three of the 
species.  Thus, based on the evidence provided by Shah and Collins, P. assacharolyticus 
can be used as a viable substitute to P. gingivalis, which can sometimes prove difficult to 
grow under laboratory conditions, to determine the relative changes in proteolytic 
activity.   
Despite the knowledge that periodontal disease is the result of specific 
microorganisms, various risk factors can modify susceptibility to the disease.  These risk 
factors include, but are by no means limited to, smoking, obesity and diabetes mellitus
7-9
.  
Perhaps the most investigated is the relationship between smoking and periodontal 
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disease.  According to the American Heart Association, an estimated 24.8 million men 
(23.1%) and 21.1 million women (18.3%) are smokers in the United States.  Sheiham 
found that smokers had more periodontal disease, as well as increased amounts of plaque 
and calculus, when compared to their nonsmoking counterparts 
10
.  When examining the 
association between cigarette smoking and interproximal bone loss, greater bone loss is 
associated with higher cigarette consumption, longer duration and higher lifetime 
exposure 
11
.   
Numerous in vitro studies have been conducted to show the various effects of 
nicotine on the oral cavity.  Teughels et al. (2005) examined whether nicotine and its 
metabolite, cotinine, could make epithelial cells more prone to colonization by 
periopathogens and found the susceptibility of these cells to P. gingivalis could only be 
moderately altered in non-physiological circumstances (high nicotine/cotinine 
concentrations, cigarette smoke condensate (CSC)) 
12
.  Further to the results found by 
Teughels et al., Cogo et al. (2008, 2009) found that nicotine and cotinine did not affect 
the growth of P. gingivalis when incubated with various concentrations of nicotine and 
cotinine 
13
; however they did report that cotinine at higher concentrations may improve 
colonization of P. gingivalis to epithelial cells only after a previous exposure 
14
.  Cogo et 
al., (2009) also stated that nicotine had no statistically significant effect on the ability of 
P. gingivalis to invade soft tissues 
14
.  Several studies have examined the effects of 
varying concentrations of nicotine on human fibroblasts and have found that nicotine 
increased the collagen-degrading ability of fibroblasts in a dose-dependent manner
15-19
.  
Bagaitkar et al. (2009) hypothesized and subsequently showed that CSC posed an 
environmental stress to P. gingivalis which results in adaptation by alteration in its 
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pattern of gene expression
20
.  In adapting to the environmental stress posed by CSC, 
Bagaitkar et al. found that cysteine proteinases were upregulated approximately 14 fold 
based on their microarray results
20
.  In vivo bacteriologic studies have not shown 
conclusively that there is a difference in the rate of plaque formation, proportion of 
anaerobes or the number of gram negative or positive bacteria in smokers versus 
nonsmokers 
21
.  However, in vitro studies have indicated that bacteria, particularly the red 
complex bacteria, are affected by cigarette smoke and that a higher mean proportion of 
anaerobes are present in the plaque of smokers
21-23
.  Therefore, evidence suggests that 
smoking exerts a negative effect on periodontal health and pathogens and can thus be a 
major contributing factor in the pathogenesis and ultimate progression of the disease.  But 
the question still remains -- how?  Studies have shown that smoking increases the levels 
of other oral bacteria including Streptococcus mutans, which is the primary 
microorganism involved in dental caries
24-26
.  Preliminary unpublished data from Zheng 
and Gregory (2008, 2009), as well as from Gregory et al. (2009) and Morgan and 
Gregory (2010), have shown that CSC and nicotine increase gene expression of adhesion 
factors along with virulence factors of S. mutans.  Evidence indicates that physiological 
concentrations of nicotine increase S. mutans growth, hydrophobicity, biofilm formation, 
acid production, glucosyltransferase, fructosyltransferase, lactate dehydrogenase, and 
glucose-phosphotransferase enzyme activities.  From this, it is evident that these effects 
work in concert to increase the virulence of S. mutans and thereby possibly increase the 
cariogenicity of the bacterium.             
Virulence factors have been implicated in the pathogenicity of periopathogens and 
are one possible explanation as they can be responsible for the inhibition of certain host 
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defense mechanisms thereby resulting in progression of disease.  The presence of 
fimbriae, lipopolysaccharide, toxic by-products and production of a capsular material, as 
well as the proteolytic activity of the various periodontopathic bacteria, have been 
associated with the pathogenesis of periodontitis
27-31
.  Many different enzymes, including 
such proteolytic enzymes as trypsin-like enzymes, chymotrypsin-like enzymes, elastase-
like enzymes and dipeptidyl peptidase-like enzymes, are produced in large quantities by 
these bacteria and have been implicated in the pathogenicity of the bacteria subsequently  
increasing the destructive potential of the different periodontal pathogenic bacteria and 
thereby mediating the destruction of the periodontal apparatus 
32
.  For example, 
gingipains, which are cysteine proteases unique to the C25 family of cysteine proteases, 
consist of arginine-specific proteases (Arg-gingipain, Rgp; 95 and 50 kDa) which have 
multiple functions and are essential for bacterial growth 
33
.  In addition, gingipains play a 
role in complement and immunoglobulin degradation 
34
, inactivation of cytokines and 
their receptors, platelet aggregation, attenuation of neutrophil antibacterial activities, 
increasing vascular permeability, prevention of blood clotting, disrupting cell-cell and 
cell-matrix adhesion, and induction of apoptosis in several cell types 
35
.  Gingipains are 
associated with P. gingivalis; however, interpain A, another cysteine protease, is 
associated with P. intermedia but further studies are required to better understand its 
specific targets and function
36
.  Other than the ability of P. intermedia to obtain haem 
from hemoglobin it is unknown how this is actually elucidated and what it means in 
terms of the pathogenesis of periodontal disease
37
.  Ogawa et al. (2006) studied and 
attempted to characterize the proteolytic activity of F. nucleatum and found that metallic, 
serine and cysteine as well as aspartic proteases were present 
38
.   
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Studies have shown that periodontopathic bacteria  are active against various 
synthetic substrates such as N-α-benzoyl-L-arginine-p-nitroanilide (BAPNA) and thus 
BAPNA can be used to determine enzymatic activity 
32
.  BAPNA is a simple colorless 
ester which is recognized by trypsin as a substrate (chromogenic substrate).  Trypsin 
cleaves the bond between the arginine and the p-nitroaniline to release free p-nitroaniline 
causing a measurable color change.  Therefore, it follows, that the proteolytic activity of 
periodontal pathogens in conjunction with various chromogenic synthetic substrates, such 
as BAPNA, can be used to determine trypsin-like proteolytic activity of P. intermedia, F. 
nucleatum and P. assacharolyticus.  
Based on the evidence that smoking has a deleterious effect on periodontal health, 
it can be speculated that smoking has an effect on the pathogenicity of the major 
periopathogens.  More specifically, it can be hypothesized that the proteolytic activity of 
periodontopathic bacteria such as, P. intermedia and F. nucleatum, is altered in the 
presence of nicotine.  Thus, the purpose of this study was to determine the effects of 
nicotine on the secreted trypsin-like cysteine proteolytic activity of P. intermedia, F. 
nucleatum and P. assacharolyticus.   
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MATERIALS AND METHODS 
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BACTERIAL STRAINS AND GROWTH CONDITIONS 
P. intermedia, F. nucleatum and P. assacharolyticus (American Type Culture 
Collection (ATCC) 25611, 10953 and 25260 respectively) were maintained on anaerobic 
blood agar plates containing 3% sheep blood.  Cultures were incubated in an anaerobic 
GasPak jar at 37°C with an atmosphere of 85% nitrogen, 10% hydrogen and 5% carbon 
dioxide and allowed to grow for 7 days prior to use for the enzyme assay.  P. intermedia, 
F. nucleatum and P. assacharolyticus cells were incubated, along with the chromogenic 
substrates with 1 mg/ml of nicotine (Sigma-Aldrich Products, St. Louis, MO, USA) for 
60 minutes during the enzyme assay.  Bacterial cells not incubated with nicotine were 
used as positive controls and the substrates alone were used as negative controls 
39
.  Each 
experimental condition was assessed at least three times.  
 
ENZYME ASSAYS 
 
The enzyme assay was carried out based on the procedure described by Cookson 
et al. 
40
 and is described as follows.  Secreted enzyme activity was measured using the 
synthetic chromogenic substrates glycyl-L-proline-p-nitroanilide (GPPNA), N-succinyl-
L-alanyl-L-alanyl-L-alanyl-p-nitroanilide (SAAAPNA), N-succinyl-alanine-alanine-
proline-phenylalanine-p-nitroanilide (SAAPPPNA) and BAPNA (Sigma).  The 
enzymatic hydrolysis was assessed in a total reaction volume of 200 µl in 50 mM-Tris 
base, pH 7.4, containing 100 µl of the washed cells and 100 µl each of the synthetic 
chromogenic substrates at a final concentration of 1.2 mM at 37°C in 96 well microtiter 
plates.   
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HARVESTING OF THE BACTERIAL CELLS AND  
PREPARATION FOR ENZYME ASSAYS 
 
The bacteria were swabbed from the anaerobic blood agar plates using sterile 
cotton swabs.  The bacteria were resuspended in 5 ml of the Tris base and centrifuged at 
3300 rpm for 10 minutes.  The resultant supernatant was removed carefully so as not to 
disturb the pellet; the bacterial cells were resuspended in Tris base to a final volume of 5 
ml.  The bacteria were centrifuged at 3300 rpm for an additional 10 minutes.  The 
resultant supernatant was removed and the bacteria were resuspended in Tris base so as to 
have an optical density of 2.0 at 600 nm as measured by an UV-visible split-beam 
scanning spectrophotometer (Milton Roy Spectronic 1201, New York, USA).  A total 
volume of 100 µl of bacteria was added to the wells of the microtiter plate.  One hundred 
microliters (100 µl) of each of the substrates (either with nicotine of 1 mg/ml final 
concentration or without) was added to the appropriate wells.  The microtiter plate was 
then incubated at 37°C for 1 hour and read every 5 minutes at 660 nm (absorbance used 
for proteolytic activity). Each substrate and bacteria combination was run in triplicate.  
The bacteria and substrate/nicotine combinations were also incubated at 37°C for 1 hour 
and read every 5 minutes at 660 nm.  The absorbance of p-nitroaniline released from the 
substrate was measured for 1 hour at 660 nm using a Molecular Devices microplate 
reader (Molecular Devices Corp, Spectra MAX 190, Sunnyvale, CA) 
41
.  Appropriate 
controls (without bacterial cells) were included to account for spontaneous hydrolysis of 
the substrate.  One unit (U) of enzyme activity corresponds to 1 nmol p-nitroaniline 
released min
-1
 at 37°C. 
 
 
 
14 
 
 
 
STATISTICAL ANALYSIS 
 
For each experiment, the secreted enzymatic activity was calculated by examining 
the absorbance at 660 nm at a time of 60 minutes.  Appropriate means and standard 
deviations were determined for each of the enzymatic activities measured and analysis of 
variance (ANOVA) was used to compare all the groups.  A 5% significance level was 
used for all comparisons. 
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RESULTS 
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The mean absorbance at 660 nm in the presence of and absence of nicotine was 
measured for P. intermedia, F. nucleatum and P. assacharolyticus using each of the 
substrates, GPPNA, SAAAPNA, SAAPPPNA and BAPNA and are presented in Tables 
1-15.  The absorbance at 660 nm of the chromogenic substrates alone were as follows:  
GPPNA 0.01; SAAAPNA 0.03; SAAPPPNA 0.02; and BAPNA 0.04.  All experiments 
were carried out three times in triplicate and a two-way repeated measures analysis of 
variance was performed to compare each of the bacteria and respective substrates in the 
presence and absence of nicotine.   
 
Porphyromonas assacharolyticus 
 
Tables 1 through 4 show the mean absorbance at 660 nm of P. assacharolyticus in 
the presence and absence of nicotine.  Table 1 illustrates the absorbance with the 
substrate GPPNA, the mean absorbance ± standard errors of the means in the absence of 
nicotine at 60 minutes was 0.59 ± 0.14, whereas in the presence of nicotine at 60 minutes 
the absorbance was 0.67 ± 0.14.  This demonstrates an increase in absorbance at 60 
minutes, albeit not statistically significant (p = 0.860).  Table 2 displays the absorbance 
with the substrate SAAAPNA, the mean absorbance ± standard errors of the means in the 
absence of nicotine at 60 minutes was 0.62 ± 0.26 and 0.68 ± 0.26 in the presence of 
nicotine.  Once again this increase in absorbance is not statistically significant at 60 
minutes (p = 0.710).  Table 3 represents the absorbance with the substrate SAAPPPNA, 
the mean absorbance ± standard errors of the means in the absence of nicotine at 60 
minutes was 0.71 ± 0.23, whereas in the presence of nicotine at 60 minutes the 
absorbance was 0.72 ± 0.23, a non-statistically significant increase once again (p = 
17 
 
 
 
0.851).  Finally, Table 4 demonstrates the absorbance with the substrate BAPNA, the 
mean absorbance ± standard errors of the means in the absence and presence of nicotine 
at 60 minutes is 0.55 ± 0.24 and 0.74 ± 0.25, respectively.  This indicates an increase in 
the absorbance, however, not statistically significant (p = 0.141).  Table 5 summarizes the 
overall change in absorbance after 60 minutes and the respective p values.  Figure 2 
depicts this data graphically.  Figures 3 and 4 demonstrate the representative proteolytic 
activity against BAPNA in the presence of nicotine and in the absence of nicotine, 
respectively, over a period of 60 min in 5 min intervals.   
 
Fusobacterium nucleatum            
 
Tables 6 through 9 depict the mean absorbance at 660 nm of F. nucleatum in the 
presence and absence of nicotine.  Table 6 illustrates the absorbance with the substrate 
GPPNA, the mean absorbance ± standard errors of the means in the absence of nicotine at 
60 minutes was 0.68 ± 0.10 whereas in the presence of nicotine at 60 minutes the 
absorbance was 0.81 ± 0.10.  This demonstrates a statistically significant increase in 
absorbance at 60 minutes (p = 0.012).  Table 7 displays the absorbance with the substrate 
SAAAPNA, the mean absorbance ± standard errors of the means in the absence of 
nicotine at 60 minutes was 0.64 ± 0.10 and 0.79 ± 0.10 in the presence of nicotine.  Once 
again this increase in absorbance is statistically significant at 60 minutes (p = 0.002).  
Table 8 represents the absorbance with the substrate SAAPPPNA, the mean absorbance ± 
standard errors of the means in the absence of nicotine at 60 minutes was 0.73 ± 0.15  
whereas in the presence of nicotine at 60 minutes the absorbance was 0.79 ± 0.15, a 
statistically insignificant increase (p = 0.451).  Finally, Table 9 demonstrates the 
18 
 
 
 
absorbance with the substrate BAPNA, the mean absorbance ± standard errors of the 
means in the absence and presence of nicotine at 60 minutes was 0.69 ± 0.08 and 0.79 ± 
0.08, respectively.  This represents a statistically significant increase in the absorbance (p 
= 0.022).  Table 10 illustrates the overall change in absorbance after 60 minutes and the 
respective p values.  Figure 5 depicts this data graphically.  Figures 6 and 7 demonstrate 
the representative proteolytic activity against SAAPPPNA in the presence of nicotine and 
in the absence of nicotine, respectively, over a period of 60 min in 5 min intervals. 
 
Prevotella intermedia 
 
Tables 11 through 14 display the mean absorbance at 660 nm of F. nucleatum in 
the presence and absence of nicotine.  Table 11 represents the absorbance with the 
substrate GPPNA, the mean absorbance ± standard errors of the means in the absence of 
nicotine at 60 minutes was 0.65 ± 0.09 whereas in the presence of nicotine at 60 minutes 
the absorbance was 0.60 ± 0.09.  This demonstrates a statistically insignificant decrease 
in absorbance at 60 minutes (p = 0.139).  Table 12 indicates the absorbance with the 
substrate SAAAPNA, the mean absorbance ± standard errors of the means in the absence 
of nicotine at 60 minutes was 0.65 ± 0.11 and 0.61 ± 0.11 in the presence of nicotine.  
Once again this decrease in absorbance is not statistically significant at 60 minutes (p = 
0.173).  Table 13 establishes the absorbance with the substrate SAAPPPNA, the mean 
absorbance ± standard errors of the means in the absence of nicotine at 60 minutes was 
0.68 ± 0.12 whereas in the presence of nicotine at 60 minutes the absorbance was 0.82 ± 
0.13, an increase, however, not statistically significant once again (p = 0.097).  Finally, 
Table 14 illustrates the absorbance with the substrate BAPNA the mean absorbance ± 
19 
 
 
 
standard errors of the means in the absence and presence of nicotine at 60 minutes was 
0.58 ± 0.08 and 0.63 ± 0.09, respectively.  This represents a statistically insignificant 
increase in the absorbance (p = 0.835).  Table 15 demonstrates the overall change in 
absorbance after 60 minutes and the respective p values.  Figure 8 depicts this data 
graphically.  Figures 9 and 10 demonstrate the representative proteolytic activity against 
SAAPPPPNA in the presence of nicotine and in the absence of nicotine, respectively, 
over a period of 60 min in 5 min intervals. 
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FIGURE 1:  Diagrammatic representation of the relationships of species within microbial 
complexes and between the microbial complexes of the major periopathogen complexes.  
Adapted from Socransky and Haffajee 2005.  
1
   
 
1.
 
Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005;38:135-87.
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 TABLE I:  Absorbance at 660 nm for Porphyromonas assacharolyticus cells with the 
chromogenic substrate glycyl-L-proline-p-nitroanilide (GPPNA) over 60 minutes with 
and without nicotine; mean and standard error of the means shown.  
 WITHOUT NICOTINE WITH NICOTINE (1 mg/ml) 
TIME 
(MIN) 
MEAN 
(n=12) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
MEAN 
(n=9) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
0 0.604 0.144 0.676 0.150 
5 0.585 0.144 0.669 0.150 
10 0.569 0.143 0.656 0.150 
15 0.560 0.143 0.651 0.149 
20 0.557 0.142 0.653 0.148 
25 0.555 0.142 0.642 0.148 
30 0.559 0.141 0.638 0.147 
35 0.562 0.141 0.634 0.147 
40 0.566 0.140 0.637 0.146 
45 0.574 0.139 0.644 0.145 
50 0.580 0.140 0.649 0.145 
55 0.587 0.139 0.662 0.144 
60 0.592 0.138 0.671 0.143 
23 
 
TABLE II:  Absorbance at 660 nm for Porphyromonas assacharolyticus cells with the 
chromogenic substrate N-succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide 
(SAAAPNA) over 60 minutes with and without nicotine; mean and standard error of the 
means shown.   
 WITHOUT NICOTINE WITH NICOTINE (1 mg/ml) 
TIME 
(MIN) 
MEAN 
(n=12) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
MEAN 
(n=9) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
0 0.668 0.260 0.686 0.268 
5 0.654 0.261 0.677 0.269 
10 0.640 0.261 0.664 0.270 
15 0.626 0.261 0.662 0.269 
20 0.621 0.260 0.659 0.268 
25 0.613 0.260 0.653 0.268 
30 0.612 0.259 0.647 0.267 
35 0.615 0.259 0.645 0.267 
40 0.618 0.258 0.646 0.266 
45 0.620 0.257 0.651 0.265 
50 0.623 0.257 0.655 0.264 
55 0.625 0.256 0.665 0.263 
60 0.619 0.255 0.675 0.262 
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TABLE III:  Absorbance at 660 nm for Porphyromonas assacharolyticus cells with the 
chromogenic substrate N-succinyl-alanine-alanine-proline-phenylalanine-p-nitroanilide 
(SAAPPPNA) over 60 minutes with and without nicotine; mean and standard error of the 
means shown.   
 WITHOUT NICOTINE WITH NICOTINE (1 mg/ml) 
TIME 
(MIN) 
MEAN 
(n=12) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
MEAN 
(n=9) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
0 0.691 0.213 0.693 0.217 
5 0.681 0.212 0.682 0.216 
10 0.672 0.212 0.677 0.216 
15 0.668 0.214 0.689 0.219 
20 0.670 0.216 0.688 0.221 
25 0.674 0.217 0.689 0.223 
30 0.684 0.220 0.687 0.226 
35 0.689 0.221 0.688 0.228 
40 0.695 0.223 0.692 0.230 
45 0.696 0.224 0.697 0.231 
50 0.696 0.224 0.705 0.231 
55 0.708 0.225 0.714 0.233 
60 0.711 0.226 0.723 0.234 
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TABLE IV:  Absorbance at 660 nm for Porphyromonas assacharolyticus cells with the 
chromogenic substrate N-α-benzoyl-L-arginine-p-nitroanilide (BAPNA) over 60 minutes 
with and without nicotine; mean and standard error of the means shown.   
 WITHOUT NICOTINE WITH NICOTINE (1 mg/ml) 
TIME 
(MIN) 
MEAN 
(n=13) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
MEAN 
(n=8) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
0 0.531 0.248 0.730 0.261 
5 0.517 0.248 0.718 0.261 
10 0.500 0.247 0.705 0.261 
15 0.490 0.247 0.697 0.260 
20 0.492 0.246 0.690 0.259 
25 0.517 0.244 0.691 0.256 
30 0.524 0.243 0.687 0.255 
35 0.526 0.243 0.689 0.254 
40 0.536 0.242 0.693 0.253 
45 0.536 0.242 0.703 0.252 
50 0.539 0.241 0.712 0.252 
55 0.546 0.241 0.723 0.251 
60 0.551 0.240 0.737 0.250 
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TABLE V:  Overall changes in absorbance at 660 nm after 60 minutes of 
incubation of Porphyromonas assacharolyticus cells with the four synthetic 
substrates.
a
 
 
Porphyromonas 
assacharolyticus 
Porphyromonas 
assacharolyticus 
with Nicotine 
Mean 
Change 
P value 
GPPNA 0.592 ± 0.138 0.671 ± 0.143 + 0.079 0.8599 
SAAAPNA 0.619 ± 0.255 0.675 ± 0.262 + 0.057 0.7098 
SAAPPPNA 0.711 ± 0.226 0.723 ± 0.234 + 0.012 0.8511 
BAPNA 0.551 ± 0.240 0.737 ± 0.250 + 0.186 0.1409 
 
a
 P value <0.05 was considered statistically significant as obtained from a two 
factor analysis of variance with replication between the two groups.  GPPNA: 
glycyl-L-proline-p-nitroanilide; SAAAPNA: N-succinyl-L-alanyl-L-alanyl-L-
alanyl-p-nitroanilide; SAAPPPNA: N-succinyl-alanine-alanine-proline-
phenylalanine-p-nitroanilide; BAPNA: N-α-benzoyl-L-arginine-p-nitroanilide.   
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FIGURE 2:  Proteolytic activity (mean ± standard errors of the means) of 
Porphyromonas assacharolyticus cells after 60 minutes of incubation with and without 
nicotine (1 mg/ml) at an absorbance of 660 nm.  Asterisks indicate significant difference 
(p<0.05) between the control and test group.  GPPNA: glycyl-L-proline-p-nitroanilide; 
SAAAPNA: N-succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide; SAAPPPNA: N-
succinyl-alanine-alanine-proline-phenylalanine-p-nitroanilide; BAPNA: N-α-benzoyl-L-
arginine-p-nitroanilide.   
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FIGURE 3:  Representative proteolytic activity (mean ± standard errors of the means) of 
Porphyromonas assacharolyticus cells over 60 minutes of incubation with nicotine (1 
mg/ml) and N-α-benzoyl-L-arginine-p-nitroanilide (BAPNA) at an absorbance of 660 
nm.   
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FIGURE 4:  Representative proteolytic activity (mean ± standard errors of the means) of 
Porphyromonas assacharolyticus cells over 60 minutes of incubation without nicotine and 
N-α-benzoyl-L-arginine-p-nitroanilide (BAPNA) at an absorbance of 660 nm.   
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TABLE VI:  Absorbance at 660 nm for Fusobacterium nucleatum cells with the 
chromogenic substrate glycyl-L-proline-p-nitroanilide (GPPNA) over 60 minutes with 
and without nicotine; mean and standard error of the means shown.   
 WITHOUT NICOTINE WITH NICOTINE (1 mg/ml) 
TIME 
(MIN) 
MEAN 
(n=12) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
MEAN 
(n=9) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
0 0.691 0.098 0.741 0.099 
5 0.672 0.097 0.727 0.098 
10 0.660 0.097 0.715 0.098 
15 0.643 0.097 0.710 0.098 
20 0.635 0.098 0.703 0.098 
25 0.639 0.098 0.708 0.099 
30 0.640 0.099 0.706 0.100 
35 0.645 0.099 0.712 0.101 
40 0.646 0.099 0.731 0.100 
45 0.658 0.100 0.753 0.101 
50 0.661 0.100 0.772 0.102 
55 0.670 0.100 0.791 0.102 
60 0.676 0.100 0.810 0.102 
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TABLE VII:  Absorbance at 660 nm for Fusobacterium nucleatum cells with the 
chromogenic substrate N-succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide 
(SAAAPNA) over 60 minutes with and without nicotine; mean and standard error of the 
means shown.   
 WITHOUT NICOTINE WITH NICOTINE (1 mg/ml) 
TIME 
(MIN) 
MEAN 
(n=12) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
MEAN 
(n=9) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
0 0.663 0.094 0.739 0.094 
5 0.646 0.094 0.727 0.094 
10 0.629 0.093 0.713 0.094 
15 0.613 0.093 0.701 0.094 
20 0.604 0.094 0.695 0.094 
25 0.606 0.094 0.692 0.095 
30 0.604 0.094 0.693 0.095 
35 0.606 0.095 0.697 0.096 
40 0.610 0.095 0.711 0.096 
45 0.619 0.095 0.734 0.097 
50 0.626 0.096 0.751 0.097 
55 0.634 0.096 0.771 0.097 
60 0.641 0.095 0.787 0.097 
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TABLE VIII:  Absorbance at 660 nm for Fusobacterium nucleatum cells with the 
chromogenic substrate N-succinyl-alanine-alanine-proline-phenylalanine-p-nitroanilide 
(SAAPPPNA) over 60 minutes with and without nicotine; mean and standard error of the 
means shown.   
 WITHOUT NICOTINE WITHOUT NICOTINE 
TIME 
(MIN) 
MEAN 
(n=12) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
MEAN 
(n=9) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
0 0.690 0.134 0.746 0.135 
5 0.686 0.134 0.741 0.135 
10 0.677 0.134 0.731 0.135 
15 0.668 0.134 0.725 0.135 
20 0.658 0.135 0.722 0.135 
25 0.658 0.136 0.720 0.137 
30 0.661 0.137 0.718 0.138 
35 0.681 0.139 0.716 0.142 
40 0.700 0.142 0.729 0.145 
45 0.713 0.145 0.743 0.149 
50 0.720 0.147 0.758 0.151 
55 0.722 0.147 0.776 0.152 
60 0.734 0.149 0.787 0.154 
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TABLE IX:  Absorbance at 660 nm for Fusobacterium nucleatum cells with the 
chromogenic substrate N-α-benzoyl-L-arginine-p-nitroanilide (BAPNA) over 60 minutes 
with and without nicotine; mean and standard error of the means shown.   
 WITHOUT NICOTINE WITH NICOTINE (1 mg/ml) 
TIME 
(MIN) 
MEAN 
(n=12) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
MEAN 
(n=9) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
0 0.691 0.077 0.747 0.078 
5 0.675 0.077 0.733 0.077 
10 0.655 0.076 0.717 0.077 
15 0.638 0.076 0.705 0.077 
20 0.631 0.076 0.703 0.077 
25 0.632 0.077 0.704 0.077 
30 0.631 0.077 0.704 0.078 
35 0.641 0.077 0.716 0.079 
40 0.646 0.078 0.731 0.079 
45 0.656 0.078 0.749 0.080 
50 0.666 0.079 0.764 0.080 
55 0.677 0.079 0.780 0.081 
60 0.689 0.080 0.793 0.081 
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TABLE X:  Overall changes in absorbance at 660 nm after 60 minutes of 
incubation of Fusobacterium nucleatum cells with the four synthetic substrates.
b
 
 
Fusobacterium 
nucleatum 
Fusobacterium 
nucleatum with 
Nicotine 
Mean 
Change 
P value 
GPPNA 0.676 ± 0.100 0.810 ± 0.102 + 0.133 0.0118 
SAAAPNA 0.641 ± 0.095 0.787 ± 0.097 + 0.146 0.0024 
SAAPPPNA 0.734 ± 0.149 0.787 ± 0.154 + 0.053 0.4506 
BAPNA 0.689 ± 0.080 0.793 ± 0.081 + 0.104 0.0218 
 
b
 P value <0.05 was considered statistically significant as obtained from a two 
factor analysis of variance with replication between the two groups.  GPPNA: 
glycyl-L-proline-p-nitroanilide; SAAAPNA: N-succinyl-L-alanyl-L-alanyl-L-
alanyl-p-nitroanilide; SAAPPPNA: N-succinyl-alanine-alanine-proline-
phenylalanine-p-nitroanilide; BAPNA: N-α-benzoyl-L-arginine-p-nitroanilide. 
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FIGURE 5:  Proteolytic activity (mean ± standard errors of the means) of Fusobacterium 
nucleatum cells after 60 minutes of incubation with and without nicotine (1 mg/ml) at an 
absorbance of 660 nm.  Asterisks indicate significant difference (p<0.05) between the 
control and test group.  GPPNA: glycyl-L-proline-p-nitroanilide; SAAAPNA: N-
succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide; SAAPPPNA: N-succinyl-alanine-
alanine-proline-phenylalanine-p-nitroanilide; BAPNA: N-α-benzoyl-L-arginine-p-
nitroanilide.   
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FIGURE 6:  Representative proteolytic activity (mean ± standard errors of the means) of 
Fusobacterium nucleatum cells over 60 minutes of incubation with nicotine (1 mg/ml) 
and N-succinyl-alanine-alanine-proline-phenylalanine-p-nitroanilide (SAAPPPNA) at an 
absorbance of 660 nm.   
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FIGURE 7:  Representative proteolytic activity (mean ± standard errors of the means) of 
Fusobacterium nucleatum cells over 60 minutes of incubation without nicotine and N-
succinyl-alanine-alanine-proline-phenylalanine-p-nitroanilide (SAAPPPNA) at an 
absorbance of 660 nm.  
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TABLE XI:  Absorbance at 660 nm for Prevotella intermedia cells with the chromogenic 
substrate glycyl-L-proline-p-nitroanilide (GPPNA) over 60 minutes with and without 
nicotine; mean and standard error of the means shown. 
 WITHOUT NICOTINE WITH NICOTINE (1 mg/ml) 
TIME 
(MIN) 
MEAN 
(n=12) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
MEAN 
(n=9) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
0 0.642 0.090 0.657 0.090 
5 0.620 0.089 0.639 0.090 
10 0.611 0.090 0.632 0.090 
15 0.613 0.090 0.633 0.090 
20 0.614 0.090 0.642 0.091 
25 0.620 0.090 0.635 0.090 
30 0.637 0.090 0.636 0.090 
35 0.639 0.090 0.621 0.090 
40 0.631 0.090 0.620 0.091 
45 0.630 0.090 0.612 0.091 
50 0.639 0.091 0.597 0.092 
55 0.636 0.091 0.604 0.092 
60 0.650 0.093 0.603 0.094 
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TABLE XII:  Absorbance at 660 nm for Prevotella intermedia cells with the 
chromogenic substrate N-succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide 
(SAAAPNA) over 60 minutes with and without nicotine; mean and standard error of the 
means shown.   
 WITHOUT NICOTINE WITH NICOTINE (1 mg/ml) 
TIME 
(MIN) 
MEAN 
(n=12) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
MEAN 
(n=9) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
0 0.650 0.102 0.657 0.102 
5 0.628 0.102 0.649 0.102 
10 0.610 0.102 0.647 0.102 
15 0.604 0.102 0.664 0.102 
20 0.614 0.102 0.647 0.102 
25 0.613 0.102 0.657 0.103 
30 0.624 0.102 0.662 0.103 
35 0.633 0.102 0.655 0.103 
40 0.623 0.103 0.644 0.103 
45 0.631 0.103 0.627 0.103 
50 0.632 0.104 0.611 0.104 
55 0.646 0.105 0.611 0.106 
60 0.648 0.106 0.607 0.108 
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TABLE XIII:  Absorbance at 660 nm for Prevotella intermedia cells with the 
chromogenic substrate N-succinyl-alanine-alanine-proline-phenylalanine-p-nitroanilide 
(SAAPPPNA) over 60 minutes with and without nicotine; mean and standard error of the 
means shown. 
 WITHOUT NICOTINE WITH NICOTINE (1 mg/ml) 
TIME 
(MIN) 
MEAN 
(n=12) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
MEAN 
(n=9) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
0 0.654 0.103 0.702 0.104 
5 0.623 0.103 0.692 0.104 
10 0.610 0.110 0.725 0.113 
15 0.612 0.117 0.754 0.122 
20 0.615 0.120 0.764 0.126 
25 0.609 0.118 0.764 0.124 
30 0.608 0.116 0.768 0.121 
35 0.625 0.118 0.800 0.123 
40 0.637 0.119 0.814 0.125 
45 0.654 0.120 0.815 0.127 
50 0.659 0.121 0.833 0.128 
55 0.694 0.124 0.832 0.132 
60 0.683 0.121 0.815 0.127 
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TABLE XIV:  Absorbance at 660 nm for Prevotella intermedia cells with the 
chromogenic substrate N-α-benzoyl-L-arginine-p-nitroanilide (BAPNA) over 60 minutes 
with and without nicotine; mean and standard error of the means shown.   
 WITHOUT NICOTINE WITH NICOTINE (1 mg/ml) 
TIME 
(MIN) 
MEAN 
(n=12) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
MEAN 
(n=9) 
STANDARD ERROR OF THE 
MEANS 
 
                
√   
  
0 0.640 0.074 0.659 0.075 
5 0.632 0.077 0.644 0.079 
10 0.603 0.073 0.661 0.074 
15 0.609 0.074 0.655 0.075 
20 0.600 0.074 0.643 0.075 
25 0.605 0.074 0.626 0.075 
30 0.620 0.075 0.621 0.076 
35 0.619 0.075 0.617 0.076 
40 0.619 0.075 0.616 0.077 
45 0.613 0.077 0.620 0.078 
50 0.598 0.079 0.624 0.081 
55 0.589 0.080 0.627 0.083 
60 0.581 0.082 0.630 0.085 
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TABLE XVV:  Overall changes in absorbance at 660 nm after 60 minutes of 
incubation of Prevotella intermedia cells with the four synthetic substrates.
c
 
 
Prevotella 
intermedia 
Prevotella 
intermedia with 
Nicotine 
Mean 
Change 
P value 
GPPNA 0.650 ± 0.093 0.603 ± 0.094 - 0.047 0.1387 
SAAAPNA 0.648 ± 0.106 0.607 ± 0.108 - 0.041 0.1727 
SAAPPPNA 0.683 ± 0.121 0.815 ± 0.127 + 0.132 0.0973 
BAPNA 0.581 ± 0.082 0.630 ± 0.085 + 0.049 0.8351 
 
c
 P value <0.05 was considered statistically significant as obtained from a two 
factor analysis of variance with replication between the two groups.  GPPNA: 
glycyl-L-proline-p-nitroanilide; SAAAPNA: N-succinyl-L-alanyl-L-alanyl-L-
alanyl-p-nitroanilide; SAAPPPNA: N-succinyl-alanine-alanine-proline-
phenylalanine-p-nitroanilide; BAPNA: N-α-benzoyl-L-arginine-p-nitroanilide.   
 
 
43 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 8:  Proteolytic activity (mean ± standard errors of the means) of Prevotella 
intermedia cells after 60 minutes of incubation with and without nicotine (1 mg/ml) at an 
absorbance of 660 nm.  Asterisks indicate significant difference (p<0.05) between the 
control and test group.  GPPNA: glycyl-L-proline-p-nitroanilide; SAAAPNA: N-
succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide; SAAPPPNA: N-succinyl-alanine-
alanine-proline-phenylalanine-p-nitroanilide; BAPNA: N-α-benzoyl-L-arginine-p-
nitroanilide.   
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FIGURE 9:  Representative proteolytic activity (mean ± standard errors of the means) of 
Prevotella intermedia cells over 60 minutes of incubation with nicotine (1 mg/ml) and N-
succinyl-alanine-alanine-proline-phenylalanine-p-nitroanilide (SAAPPPNA) at an 
absorbance of 660 nm.  
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FIGURE 10:  Representative proteolytic activity (mean ± standard errors of the means) of 
Prevotella intermedia cells over 60 minutes of incubation without nicotine and N-
succinyl-alanine-alanine-proline-phenylalanine-p-nitroanilide (SAAPPPNA) at an 
absorbance of 660 nm.  
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DISCUSSION  
47 
 
 
 
Nicotine is one of the main components of cigarette smoke and its effects upon 
the periodontium and the progression of periodontal disease is well studied.  Numerous 
studies have shown, without a doubt, the effects of nicotine on not only the subgingival 
microflora but also on the periodontium as well as gingival fibroblasts 
10-17, 20-23, 42, 43
.  
The effects of nicotine and smokeless tobacco on various immune factors had been 
studied
44-47
.  Gregory et al. found that smokeless tobacco users have significantly 
increased levels of IgA and J chain when compared to non-users 
46
.  This study ultimately 
found that smokeless tobacco affects the ability of the secretory component to bind to 
IgA without a loss in antibody function 
46
.  In a subsequent study, Gregory et al. 
examined the effect of smokeless tobacco on mucosal immune factors and found that 
significantly more salivary IgA, IgA2 and J-chain was seen in users when compared to 
non-users
45
.  This suggests that smokeless tobacco has an effect on secretory epithelial 
cells which are ultimately responsible for the synthesis of secretory component, lysozyme 
and lactoferrin along with the packaging of secretory component on IgA
45
.  In 1996, 
Gregory and Gfell reported on the effects of nicotine on the ability of secretory epithelial 
cells to  synthesize secretory component 
44
.  They found that nicotine significantly 
decreased the synthesis of secretory component, lactoferrin and lysozyme in the presence 
of smokeless tobacco or cotinine 
44
.  From this study they concluded that nicotine, 
cotinine and smokeless tobacco have an antagonistic effect on the synthesis and secretion 
of secretory component, lactoferrin and lysozyme 
44
.  In 2005, Olson et al. examined the 
effect of nicotine on the release of IL-6 by periodontal ligament fibroblast cells 
47
.  After 
exposure of the periodontal ligament fibroblasts to nicotine levels varying from 375 to 
1500 µg/ml for a period of 24 hours, the cells exhibited an increase in release of IL-6 
47
.  
48 
 
 
 
Until now little is known of the effect of nicotine on the virulence factors of 
periodontopathic bacteria. 
Periodontal disease is an inflammatory process induced by supra-gingival and 
subgingival microbial biofilm.  In 1976, Page and Schroeder described the stages of 
periodontal disease based on histological and ultrastructural features of gingival tissues
48
.  
The initial lesion most closely correlates with preclinical gingivitis and appears 2 to 4 
days after plaque accumulation in previously healthy gingiva and is localized to the 
gingival sulcus, including the junctional epithelium and the most coronal part of the 
connective tissue, rarely involving more than 5 to 10% 
48, 49
.  Characteristics of the initial 
lesion include: 1) vasculitis subsequent to the junctional epithelium; 2) extravascular 
fibrin and serum protein; 3) loss of perivascular collagen; 4) increased migration of 
leukocytes into the junctional epithelium and sulcus; 5) alteration of the coronal part of 
the junctional epithelium; and 6) increased crevicular fluid 
48, 49
.  The early lesion 
correlates with early gingivitis clinically and appears 4 to 7 days after plaque 
accumulation and is characterized by a dense lymphoid infiltrate
48, 49
.  Characteristics of 
the early lesion include: 1) features of initial lesion are present and progress; i.e., gingival 
crevicular fluid (GCF) increases with inflammation and crevicular leukocytes peak at 4 to 
7 days; 2) collagen loss increases and may reach 60% to 70% in the inflamed tissue; 3) 
cytoplasmic alterations appear in resident fibroblasts; 4) lymphoid cells accumulate 
subjacent to the junctional epithelium and make up approximately 75% of the infiltrate 
resulting in approximately 5 to 15% of the total connective tissue being affected; and 5) 
basal cells of the junctional epithelium begin to proliferate 
48, 49
.  Lymphoid cells have a 
non-specific affinity for inflamed tissue and cellular hypersensitivity may play a role in 
49 
 
 
 
the early lesion
48, 49
.  The established lesion clinically is related to chronic adult gingivitis 
and occurs 2 to 3 weeks after the beginning of plaque accumulation
48, 49
.  Characteristics 
include: 1) persistence of the manifestations of acute inflammation; 2) continued loss of 
connective tissue: fibrosis and scarring may also occur; 3) predominance of plasma cells 
without appreciable bone loss; 4) extravascular immunoglobulins; and 5) the 
proliferation, apical migration, and lateral extension of the junctional epithelium 
48, 49
. 
The established lesion may remain stable for extended periods of time
48, 49
.  The 
predominant immunoglobin is IgG with a small but significant amount of IgA and rarely 
IgM
48, 49
. 
Different host mechanisms, such as the phagocytic action of neutrophils that 
migrate continuously through the junctional epithelium into the gingival sulcus typically 
are able to maintain a normal environment for the host bacterial flora; however, once this 
balance is disturbed and more pathogenic bacteria accumulate, the host is challenged 
50, 
51
.  In response to this challenge, the epithelial cells within the periodontal pocket initiate 
the inflammatory response which then leads to cell activation within the connective tissue 
compartment and the recruitment of neutrophils into the gingival crevice 
50, 51
.  
Pathogenic bacteria induce epithelial cells to secrete IL-1β, TNF-α, IL-6 and IL-8.  At the 
same time, virulence factors that have diffused in the connective tissue, along with as 
well as IL-1β, TNF-α, IL-6 and IL-8 in turn stimulate macrophages, fibroblasts and mast 
cells to further produce and release pro-inflammatory cytokines, chemotactic molecules, 
prostaglandins, histamine and leukotrienes, as well as matrix metalloproteinases (MMPs) 
that begin the degradation of collagen 
50, 51
.  
50 
 
 
 
Adaptive immunity involves primarily lymphocytes and can be divided into B 
cells and T cells, both of which have the ability to defend against foreign antigens
50, 52
.  B 
cells primarily produce antibodies, whereas helper T and regulatory T cells help to 
regulate the immune response by releasing a variety of regulatory cytokines
50, 52
.  T 
helper type 1 (Th1) cells principally secrete IL-2 and interferon-γ (IFN-γ), while T helper 
type 2 (Th2) cells secrete predominantly IL-4, IL-5, IL-10, and IL-13
50, 52
. Ultimately, 
whether the Th1 or Th2 response dominates will determine the outcome of the infection 
and the fate of the tissues at the inflammatory site
52-55
. The most critical factor for the 
development of Th1 or Th2 phenotype is the cytokines available in the local 
microenvironment
50, 52
.  
The other mechanism by which periodontal destruction can progress is through 
the proteolytic activity of enzymes produced by not only the host but also the 
periodontopathic bacteria.  Examples of proteolytic enzymes include: elastase, dentilisin, 
dipeptidyl peptidase IV and trypsin-like proteases.  Periodontal disease and smoking and 
the effects upon the periodontium are well studied.  Numerous studies have shown, 
without a doubt, the effects of nicotine, the primary component of cigarette smoke, on not 
only the subgingival microflora but also on the periodontium as well as gingival 
fibroblasts 
10-17, 20-23, 42, 43
.         
Previous studies examining the effect of nicotine on the proteolytic activity of 
cariogenic bacteria have shown a significant difference between nicotine users and non-
users and subsequent increases in virulence
56-58
.  Based on these previous studies, we 
examined the effects of nicotine on periodontopathic bacteria.  This study of the 
proteolytic activity of various periodontal pathogens with and without exposure to 
51 
 
 
 
nicotine and with various chromogenic substrates showed both statistically significant as 
well as statistically insignificant increases, as well as decreases in activity (Tables 5, 10, 
15).  Only F. nucleatum showed statistically significant increases in proteolytic activity 
with all but one of the substrates in the presence of nicotine; however, P. 
assacharolyticus as well as P. intermedia showed a statistically insignificant increases 
along with decreases in proteolytic activity in the presence of nicotine.  
The synthetic chromogenic substrates used in these experiments are indicative of 
specific proteolytic activity.  Glycyl-L-proline-p-nitroanilide (GPPNA) is typically 
utilized when dipeptidyl peptidase IV-like activity is to be assessed
40, 59
.  Dipeptidyl 
peptidase IV is a dipeptidyl peptide hydrolase which cleaves peptides with an N-terminal 
sequence of X-Pro-Y to yield X-Pro and Y
59, 60
.  Dipeptidyl peptidase IV has been 
implicated in the metabolism of connective tissue primarily because of its affinity for the 
penultimate proline
59, 61
.  Specifically, dipeptidyl peptidase IV has been shown to destroy 
already partially degraded type I collagen thereby contributing to the further destruction 
of the periodontal ligament and the progression of periodontal disease
62, 63
.  The 
proteolytic activity of P. assacharolyticus and F. nucleatum demonstrated an increase in 
activity when incubated with nicotine and GPPNA whereas P. intermedia showed a 
decrease.  The only bacterium which exhibited these changes with any statistical 
significance was F. nucleatum.  
N-succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide (SAAAPNA) is normally 
used to ascertain elastase-like activity of a microorganism.  Elastase has been described 
as a potent protease with the ability to degrade various connective tissue components 
such as elastin, proteoglycans, laminin, fibronectin and collagen
64-67
.  Studies have shown 
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that peripheral neutrophils may become hyperactive when exposed to certain 
periodontopathic bacteria such F. nucleatum and may stimulate significant reactive 
oxygen species generation, cytokine and elastase production which could subsequently 
result in tissue damage
68, 69
.  Katsuragi et al. (2003) noted that F. nucleatum may be 
crucial in the neutrophil-dependent, reactive oxygen species induced damage of tissue 
within the periodontium as seen in the increased generation of reactive oxygen species 
upon phagocytosis of the bacterium
69, 70
.  When the periodontopathic bacteria were 
incubated with SAAAPNA, an increase in proteolytic activity was seen with F. 
nucleatum and P. assacharolyticus but a decrease in activity was seen with P. intermedia, 
once again with statistical significance seen with the increase in proteolytic activity only 
with F. nucleatum.   
N-succinyl-alanine-alanine-proline-phenylalanine-p-nitroanilide (SAAPPPNA) is 
generally indicative of chymotrypsin-like activity (dentilisin activity) of a bacterium.  
Dentilisin is a prolyl-phenylalanine specific surface protease and a major pathogen of the 
red complex bacterium T. denticola
71, 72
.  Dentilisin hydrolyzes host bioactive proteins
71, 
73
 and is ultimately cytotoxic to periodontal ligament epithelial cells
71, 74
.  Dentilisin, in 
conjunction with other surface proteins, has been thought to be the direct cause of the 
cytopathic effects seen on epithelial cells such as loss of desmosomal attachment and 
pericellular fibronectin
63, 74
.  Dentilisin has also been implicated in the migration of T. 
denticola primarily due to its ability to compromise the basement membrane, fibronectin,  
laminin and type IV collagen allowing for penetration of the host tissues thus 
contributing, once again, to the progression of periodontal disease 
63, 75
.  The proteolytic 
activity of all three of the periodontal pathogens studied demonstrated an increase in 
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activity when tested with SAAPPPNA; however the increases seen in the proteolytic 
activity demonstrated no statistical significance with any of the bacteria examined.  
Finally, N-α-benzoyl-L-arginine-p-nitroanilide (BAPNA) is utilized when trypsin-
like activity of a microorganism is to be assessed.  Trypsin cleaves the bond between the 
arginine and the p-nitroaniline to release free p-nitroaniline causing a measurable color 
change.  Therefore, it follows, that the trypsin-like activity of the cysteine proteolytic 
gingipains can be used with BAPNA to determine proteolytic activity of P. gingivalis and 
other proteolytic microorganisms.  Trypsin-like activity of the red complex bacteria  is 
well studied in the literature and has been reported to have the ability to degrade 
collagens, proteoglycans, fibronectin and the basement membrane which effectively 
destroys the periodontal connective tissues thereby enabling invasion of host tissues; 
inactivate host defense proteins; and impede tissue repair of the periodontal lesion by 
altering the ability of clot formation or by lysing of the fibrin matrix 
76
.  The trypsin-like 
activity of P. intermedia, more specifically, has been shown to have the ability to degrade 
IgG as well as fibronectin which in doing so reduces the effectiveness of the host immune 
and inflammatory defenses
76-79
.  All three of the periodontopathic bacteria studied 
exhibited an increase in proteolytic activity when incubated with nicotine and 
subsequently tested with BAPNA; however, once again, only F. nucleatum demonstrated 
this increase with any statistical significance.  Since nicotine affects the proteolytic 
activity of F. nucleatum, P. intermedia and P. assacharolyticus this may have 
implications in the progression of periodontal disease. 
F. nucleatum is a gram-negative anaerobic bacterium associated with gingivitis 
and chronic periodontitis but is also implicated in other infections
50, 80, 81
.  Not only does 
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F. nucleatum have the ability to co-aggregate with many plaque bacteria, effectively 
acting as a sort of microbial bridge but it can also initiate physio-chemical changes 
within the gingival sulcus which allows for pathogenic successors to not only establish 
themselves but to also allow for subsequent proliferation 
50
.  Studies have also suggested 
that F. nucleatum facilitates invasion of host cells by P. gingivalis 
50, 82
, has been 
demonstrated to be a significant marker for destructive periodontal disease in adults 
50, 83-
85
, has been seen more often in active diseased sites and is always present whenever T. 
denticola and P. gingivalis are present 
50, 86-88
.  This confirms the notion that F. 
nucleatum might be required for colonization of subsequent pathogenic successors.  
Based on the work by Kolenbrander et al., (2002) early and late colonizers of bacterial 
plaque tend not to co-aggregate with one another but do co-aggregate with F. nucleatum 
which, to some degree, explains why F. nucleatum is abundant in diseased as well as 
healthy periodontal sites 
87
.  They also described the presence of adhesins on the surfaces 
of F. nucleatum, which appear to be mediated by galactose-binding adhesins,  and 
cognate receptors on the surfaces of those bacteria, such as P. gingivalis and P. 
intermedia, which competitively bind with F. nucleatum 
87, 89
.                         
P. intermedia is a black-pigmented gram-negative obligate anaerobic non-motile 
rod and is prevalent in patients with chronic periodontitis, aggressive periodontitis and 
acute necrotizing ulcerative gingivitis
50, 88, 90-92
.  Several proteolytic enzymes have been 
described including trypsin-like serine proteases and a dipeptidyl peptidase IV
50, 93-95
.  P. 
intermedia also possess various types of fimbriae which may mediate the adherence of 
the bacterium to various surfaces 
50
. 
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Even though P. assacharolyticus is a suitable substitute, based on the similarities 
of the biochemical and chemical properties, for P. gingivalis in most respects based on 
the evidence provided by Shah and Collins, it is still not identical 
6
.  Both P. 
assacharolyticus and P. gingivalis are gram-negative, obligately anaerobic, non-spore 
forming, non-motile rods or coccobacilli and both form colonies on blood agar plates 
which are smooth, shiny (P. gingivalis can be rough sometimes), convex and 1 to 3 mm 
in diameter and darken progressively from the edge of the colony toward the center after 
6 to 10 days in the case of P. assacharolyticus and 4 to 8 days in the case of P. 
gingivalis
6
.  However this is where subtle differences become apparent.  P. gingivalis 
colonies are always black pigmented with non-pigmented colonies rarely occurring 
whereas P. assacharolyticus colonies become progressively pigmented due to increased 
protoheme production 
6
.  The proteolytic activities of each are different:  proteolytic 
activity for P. assacharolyticus is low but gelatin liquefaction is positive and fibrinolytic 
activity is present and can produce indole; P. gingivalis has proteases (i.e., trypsin-like 
enzyme and collagenase) and can produce indole 
6
.  Indole formation has been shown to 
be present in greater numbers in the saliva of patients with periodontitis and is 
representative of the putrefactive end products normally seen in periodontal breakdown
96-
98
.    
 According to Eley et al in 2003, the proteolytic activity of putative periodontal 
bacteria without the presence of nicotine is varied 
76
.  They found that F. nucleatum did 
not exhibit any dipeptidyl peptidase IV-like, elastase-like, chymotrypsin-like or trypsin-
like activity based on bacterial cell sonicates in the absence of nicotine.  In examining the 
data presented here, there was a statistically significant increase in the proteolytic activity 
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in the presence of nicotine with the aforementioned proteases (only the chymotrypsin-like 
activity was statistically insignificant).  Eley et al also demonstrated that P. gingivalis has 
an increased protease activity of dipeptidyl peptidase IV and of trypsin-like proteases but 
no activity of the elastase-like or the chymotrypsin-like protease.  Once again, the data 
presented here suggests an increased, but not statistically significant, trend in proteolytic 
activity in the presence of nicotine with all four of the proteases examined when 
incubated with P. assacharolyticus.  Finally, the authors stated that P. intermedia 
demonstrated an increased protease activity of dipeptidyl peptidase IV and trypsin like 
proteases and no activity of the elastase-like or the chymotrypsin-like protease in the 
absence of nicotine.  The data presented here suggests that there is an increased trend in 
the proteolytic activity of the chymotrypsin-like and the trypsin-like proteases and a 
decreased trend in the proteolytic activity of dipeptidyl peptidase IV and elastase-like 
activity when incubated with nicotine.  These conclusions can only be made as 
extrapolations of the data that Eley et al presented and based on the known effects of 
nicotine on the periodontal apparatus and not necessarily from the data presented here 
directly due to a lack of statistical significance.   
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SUMMARY AND CONCLUSIONS 
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Based on the results of this study, it can be concluded that in the presence of 1 
mg/ml of nicotine the dipeptidyl peptidase, elastase, chymotrypsin and trypsin-like 
proteolytic activity of the periodontal pathogens F. nucleatum and P. assacharolyticus 
demonstrated a trend of increased activity, albeit without any statistical significance in 
the case of P. assacharolyticus, after a period of 60 minutes.  More specifically, however, 
statistically significant increases in the proteolytic activity of dipeptidyl peptidase, 
elastase and trypsin-like proteases were seen with F. nucleatum in the presence of 1 
mg/ml of nicotine.  However, the dipeptidyl peptidase, elastase, chymotrypsin and 
trypsin-like proteolytic activity of P. intermedia exhibited a trend in increased activity 
only with the substrates SAAPPPNA and BAPNA and a trend of decreased activity with 
GPPNA and SAAAPNA, once again without demonstrating any statistical significance.  
Therefore, it could be concluded that based on these results nicotine at a concentration of 
1 mg/ml may increase the proteolytic activity of periodontal pathogens and thus may 
increase periodontal disease activity and subsequent periodontal breakdown.  Further 
studies are needed to validate these results utilizing different concentrations of nicotine.   
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EFFECTS OF NICOTINE ON THE PROTEOLYTIC  
ACTIVITY OF PERIODONTAL  
PATHOGENS 
 
by 
Janice Kaeley 
Indiana University, School of Dentistry 
Indianapolis, Indiana 
 
Periodontal disease is the leading cause of tooth loss in adults.  Bacterial biofilm 
on tooth surfaces is the primary initiator of periodontal disease.  Various factors 
contribute to the severity of periodontal disease including the different virulence factors 
of the bacteria within the biofilm.  In the progression of periodontal disease, the 
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microflora evolves from a predominantly Gram positive microbial population to a mainly 
Gram negative population.  Specific gram negative bacteria with pronounced virulence 
factors have been implicated in the etiology and pathogenesis of periodontal disease, 
namely Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola which 
form the red complex of bacteria.  The orange complex bacteria become more dominant 
in the maturation process of dental plaque and act to bridge the early colonizers of plaque 
with the later more dominant red complex bacterial and consists of such bacteria as 
Campylobacter showae, Campylobacter rectus, Fusobacterium nucleatum and Prevotella 
intermedia.  Perhaps the most investigated contributing factor is the relationship between 
smoking and periodontal disease.  When examining the association between cigarette 
smoking and interproximal bone loss, greater bone loss is associated with higher cigarette 
consumption, longer duration (i.e., pack year history) and higher lifetime exposure.  The 
presence of various virulence factors such as the production of a capsular material, as 
well as the proteolytic activity of the various periopathodontic bacteria has been 
associated with the pathogenesis of periodontitis.  Even though many different enzymes 
are produced in large quantities by these periodontal bacteria, trypsin-like enzymes, 
chymotrypsin-like enzymes and elastase-like enzymes, as well as dipeptidyl peptidase-
like enzymes, have been thought to increase the destructive potential of the bacterium and 
mediate destruction of the periodontal apparatus.  More specifically, it is hypothesized 
that the proteolytic activity of other clinically important periodontal pathogens, such as 
Fusobacterium nucleatum, Prevotella intermedia and Porphyromonas assacharolyticus, 
is increased in the presence of nicotine.    The purpose of this study was to determine the 
effects of nicotine on F. nucleatum, P. intermedia and P. assacharolyticus proteolytic 
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activity.  Cultures were maintained on anaerobic blood agar plates containing 3% sheep 
blood.  Bacterial cells were harvested from the plates and washed.  Washed F. nucleatum, 
P. intermedia and P. assacharolyticus cells were incubated with 1 mg/ml of nicotine.  
Bacterial cells not incubated with nicotine were used as positive controls.  Secreted 
enzymatic activity was measured using the synthetic chromogenic substrates glycyl-L-
proline-p-nitroanilide (GPPNA), N-succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide 
(SAAAPNA), N-succinyl-alanine-alanine-proline-phenylalanine-p-nitroanilide 
(SAAPPPNA) and N-α-benzoyl-L-arginine-p-nitroanilide (L-BAPNA) (Sigma-Aldrich 
Products, St. Louis, MO, USA).  Appropriate means and standard deviations were 
determined for each of the enzymatic activities measured and analysis of variance 
(ANOVA) was used to compare the groups utilizing a 5% significance level for all 
comparisons.  Results demonstrated that after 60 minutes of incubation of  F. nucleatum, 
P. intermedia and P. assacharolyticus cells with 1 mg/ml of nicotine and the various 
synthetic substrates, had the following proteolytic activity for GPPNA: 0.83 ± 0.14, 0.72 
± 0.03 and 0.67 ± 0.10,  respectively; SAAAPNA: 0.82 ± 0.06, 0.76 ± 0.05 and 0.68 ± 
0.08, respectively; SAAPPPNA: 0.90 ± 0.13, 0.85 ± 0.17 and 0.72 ± 0.03, respectively; 
and BAPNA: 0.81 ± 0.15, 0.74 ± 0.13 and 0.74 ± 0.16, respectively.  In conclusion, the 
results indicate that in the presence of 1 mg/ml of nicotine, the proteolytic activity of F. 
nucleatum and P. assacharolyticus was increased with all of the synthetic substrates 
(with statistical significance seen only in the increases with F. nucleatum  and GPPNA, 
SAAAPNA and BAPNA).  The proteolytic activity exhibited an increasing trend in 
activity for P. intermedia with SAAPPPNA and BAPNA but a decreasing trend in 
activity with GPPNA and SAAAPNA when incubated with 1 mg/ml of nicotine, once 
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again demonstrating no statistical significance for any of the substrates.  Therefore, it 
could be concluded that based on these results nicotine at a concentration of 1 mg/ml may 
increase the proteolytic activity of periodontal pathogens and thus may increase 
periodontal disease activity and subsequent periodontal breakdown.  Further studies are 
needed to validate these results utilizing different concentrations of nicotine.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CURRICULUM VITAE
Janice Kaeley 
 
 
 
 
 
August 22, 1976      Born in Oshawa, Ontario, Canada 
 
May 1999   Honours Bachelor of Science 
University of Toronto 
Toronto, Ontario, Canada 
 
December 2004     Bachelor of Dental Science 
University of Melbourne 
School of Dentistry 
Melbourne, Victoria, Australia 
 
May 2008      Doctor of Dental Surgery 
University of Southern California 
School of Dentistry 
Los Angeles, California 
 
August 2011      Masters of Science Dentistry, 
Department of Graduate Periodontics 
Indiana University  
School of Dentistry 
Indianapolis, Indiana 
 
 
Professional Organizations 
 
Omicron Kappa Upsilon 
Phi Kappa Phi 
American Dental Association 
American Academy of Periodontology 
California Dental Association 
 
